Olivier Bohuon - Smith Nephew Insider

SNNUF -- USA Stock  

USD 17.09  0.16  0.93%

CEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance Committee
Mr. Olivier Bohuon is no longer serves as Chief Executive Officer, Executive Director of Smith and Nephew PLC., effective from 7 May 2018. Olivier holds a doctorate in Pharmacy from the University of Paris and an MBA from HEC, Paris. He started his career in Morocco with Roussel Uclaf S.A. and then, with the same company, held a number of positions in the Middle East with increasing levels of responsibility. He joined Abbott in Chicago as head of their antiinfective franchise with Abbott International before becoming Pharmaceutical General Manager in Spain. He subsequently joined GlaxoSmithKline plc, rising to Senior Vice President Director for European Commercial Operations. He then rejoined Abbott as President for Europe, became President of Abbott International, and then President of their Pharmaceutical Division. He joined Smith Nephew from Pierre Fabre, where he was Chief Executive. Olivier has extensive international healthcare leadership experience within a number of significant pharmaceutical and healthcare companies. His global experience provides the skillset required to innovate a FTSE 100 company with a deep heritage and provide inspiring leadership.
Age: 58  Chairman Since 2011  MBA    
44 20 7401 7646  http://www.smith-nephew.com

Management Efficiency

The company has return on total asset (ROA) of 7.27 % which means that it generated profit of $7.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 17.83 % meaning that it generated $17.83 on every $100 dollars invested by stockholders.
The company has accumulated 1.45 B in total debt with debt to equity ratio (D/E) of 31.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Smith Nephew plc has Current Ratio of 1.99 which is within standard range for the sector.

Similar Executives

Entity Summary

Smith Nephew plc designs, develops, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom. Smith Nephew is traded on OTC Market in USA.Smith Nephew plc (SNNUF) is traded on OTC Market in USA. It is located in 15 Adam Street and employs 15,933 people.

Smith Nephew plc Leadership Team

Namal Nawana, CEO
Michael Friedman, Director, Ph.D
Diogo MoreiraRato, President
Erik Engstrom, Director, MBA
Matthew Stober, President
Marc Owen, Director, MBA
Rodrigo Bianchi, President
Brian Larcombe, Director
Elga Lohler, Executive
Gunthorp Oie, Executive
Roland Diggelmann, Director
Helen Maye, Executive
Vinita Bali, Director, MBA
Olivier Bohuon, Chairman, MBA
Graham Baker, Director
Roberto Quarta, Chairman
Cyrille Petit, Executive
Julie Brown, Director, MBA
Glenn Warner, President
Robin Freestone, Director
Virginia Bottomley, Director
Angie Risley, Director
Vasant Padmanabhan, President, MBA
Michael Frazzette, President
Joseph Papa, Director, MBA
Ingeborg Oie, VP
Susan Swabey, Executive
Gordon Howe, President
John Campo, Executive
Brad Cannon, President
Ian Barlow, Director
Catheryn ORourke, Executive

Stock Performance Indicators

Current Sentiment - SNNUF

Smith Nephew plc Investor Sentiment
Most of Macroaxis users are at this time bullish on Smith Nephew plc. What is your outlook on investing in Smith Nephew plc? Are you bullish or bearish?
98% Bullish
2% Bearish
Currently Active Assets on Macroaxis
Purchased over 20 shares of
few hours ago
Traded for 104.4
Purchased over 20 shares of
few hours ago
Traded for 140.13
Purchased over 40 shares of
few hours ago
Traded for 68.99
Purchased over 100 shares of
few hours ago
Traded for 25.0
Purchased over 200 shares of
few hours ago
Traded for 10.82
Also please take a look at World Market Map. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.